Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital reiterated a “buy” rating and issued a $10.00 target price on shares of Cytosorbents in a research note […]
StockNews.com began coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital reiterated a “buy” rating and issued a $10.00 target price on shares of Cytosorbents in a research note […]
